{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T20:21:41Z","timestamp":1790194901055,"version":"4.1.0"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2013,6,28]],"date-time":"2013-06-28T00:00:00Z","timestamp":1372377600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1007\/s12035-013-8495-6","type":"journal-article","created":{"date-parts":[[2013,6,27]],"date-time":"2013-06-27T06:08:34Z","timestamp":1372313314000},"page":"363-367","source":"Crossref","is-referenced-by-count":25,"title":["Progress in Dodecafluoropentane Emulsion as a Neuroprotective Agent in a Rabbit Stroke Model"],"prefix":"10.1007","volume":"48","author":[{"given":"S. D.","family":"Woods","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. D.","family":"Skinner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. M.","family":"Ricca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. T.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. D.","family":"Lowery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. J.","family":"Borrelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. O.","family":"Lay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W. C.","family":"Culp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,6,28]]},"reference":[{"issue":"3","key":"8495_CR1","first-page":"1","volume":"60","author":"K Kochanek","year":"2011","unstructured":"Kochanek K, Xu J, Murphy SL, Minino AM, Kung H-C (2011) Deaths: Final data for 2009. Natl Vital Stat Rep 60(3):1\u2013117","journal-title":"Natl Vital Stat Rep"},{"key":"8495_CR2","doi-asserted-by":"crossref","first-page":"e2","DOI":"10.1161\/CIR.0b013e31823ac046","volume":"125","author":"VL Roger","year":"2012","unstructured":"Roger VL et al (2012) AHA statistical update: heart diseases and stroke statistics\u20132012 Update. Circulation 125:e2\u2013e220, ePub Dec 15, 2011","journal-title":"Circulation"},{"issue":"9849","key":"8495_CR3","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1016\/S0140-6736(12)61384-1","volume":"380","author":"JL Saver","year":"2012","unstructured":"Saver JL, Jahan R, Levy EI, Jovin TG, Baxter B, Nogueira RG, Clark W, Budzik R, Zaidat OO, Trialists SWIFT (2012) Solitaire flow restoration device versus the Merci Retriever in patients with acute ischemic stroke (SWIFT): a randomized, parallel-group, non-inferiority trial (2012). Lancet 380(9849):1241\u20131249","journal-title":"Lancet"},{"key":"8495_CR4","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1161\/STROKEAHA.107.493296","volume":"39","author":"GA Donnan","year":"2009","unstructured":"Donnan GA (2009) The 2007 Feinberg lecture: a new road map for neuroprotection. Stroke 39:242\u2013248","journal-title":"Stroke"},{"key":"8495_CR5","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1161\/STROKEAHA.107.503334","volume":"39","author":"HC Diener","year":"2008","unstructured":"Diener HC, Lees KR, Lyden P, Grotta J, Davalos A, Davis SM, Shuaib A, Ashwood T, Wasiewski W, Alderfer V, Hardemart HG, Rodichok L, SAINT I and II Investigators (2008) NXY-059 for the treatment of acute stroke: pooled analysis of the SAINT I and II Trials. Stroke 39:1751\u20131758","journal-title":"Stroke"},{"issue":"3","key":"8495_CR6","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1161\/STROKEAHA.111.628537","volume":"43","author":"Heiss WD, Brainin M, Bornstein NM, Tuomilehto J, Hong Z, Cerebrolysin Acute Stroke Treatment in Asia (CASTA) Investigators","year":"2012","unstructured":"Heiss WD, Brainin M, Bornstein NM, Tuomilehto J, Hong Z, Cerebrolysin Acute Stroke Treatment in Asia (CASTA) Investigators (2012) Cerebrolysin in patients with acute ischemic stroke in Asia: result of a double-blind, placebo-controlled randomized trial. Stroke 43(3):630\u2013636","journal-title":"Stroke"},{"key":"8495_CR7","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1080\/10731190903043192","volume":"37","author":"JLC Johnson","year":"2009","unstructured":"Johnson JLC, Dolezal MC, Kerschen A, Matsunaga TO, Unger EC (2009) In vitro comparison of dodecafluoropentane (DDFP), perfluorodecalin (PFD), and perfluoroctylbromide (PFOB) in the facilitation of oxygen exchange. Artif Cell Blood 37:156\u2013162","journal-title":"Artif Cell Blood"},{"key":"8495_CR8","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.jvir.2011.10.001","volume":"23","author":"WC Culp","year":"2012","unstructured":"Culp WC, Woods SD, Skinner RD, Brown AT, Lowery JD, Johnson JLH, Unger EC, Hennings LJ, Borrelli MJ, Roberson PK (2012) Dodecafluoropentane emulsion decreases infarct volume in a rabbit ischemic stroke model. J Vasc Interv Radiol 23:116\u2013121","journal-title":"J Vasc Interv Radiol"},{"issue":"S1","key":"8495_CR9","first-page":"11","volume":"51","author":"JM Correas","year":"1996","unstructured":"Correas JM, Quay SC (1996) EchoGen emulsion: a new ultrasound contrast agent based on phase shift colloids. Clin Radiol 51(S1):11\u201314","journal-title":"Clin Radiol"},{"key":"8495_CR10","unstructured":"Culp WC, Woods SD, Brown AT, Lowery JD, Hennings LJ, Skinner RD, Borrelli MJ, Roberson PK. Three variations in rabbit angiographic stroke models. J Neurosci Meth, Epub ahead of print Nov 8 2012, doi: 10.1016\/j\/jneurometh.2012.10.107"},{"key":"8495_CR11","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1081\/BIO-200046659","volume":"33","author":"JG Reiss","year":"2005","unstructured":"Reiss JG (2005) Understanding the fundamentals of perfluorocarbons and perfluorocarbon emulsions relevant to in vivo oxygen delivery. Artif Cells Blood Substit Immobil Biotechnol 33:47\u201363","journal-title":"Artif Cells Blood Substit Immobil Biotechnol"},{"key":"8495_CR12","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1258\/0007142991902259","volume":"55","author":"B Remy","year":"1999","unstructured":"Remy B, Deby-Dupont G, Lamy M (1999) Red blood cell substitutes: fluorocarbon emulsions and haemoglobin solutions. Br Med Bull 55:277\u2013298","journal-title":"Br Med Bull"},{"key":"8495_CR13","unstructured":"The European Agency for the Evaluation of Medicinal Products Human Medicines Evaluation Unit, 27 July 1998, CPMP\/1342\/98"},{"key":"8495_CR14","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1080\/10731190600769271","volume":"34","author":"CEG Lundgren","year":"2006","unstructured":"Lundgren CEG, Bergoe GW, Tyssebotn IM (2006) Intravascular fluorocarbon-stabilized microbubbles protect against fatal anemia in rats. Artif Cell Blood Sub 34:473\u2013486","journal-title":"Artif Cell Blood Sub"},{"issue":"2","key":"8495_CR15","doi-asserted-by":"crossref","first-page":"79","DOI":"10.3109\/10731191003634679","volume":"38","author":"IM Tyssebotn","year":"2010","unstructured":"Tyssebotn IM, Lundgren CE, Olszowka AJ, Bergoe GW (2010) Hypoxia due to shunts in pig lung treated with O2 and fluorocarbon-derived intravascular microbubbles. Artif Cells Substit Immobil Biotechnol 38(2):79\u201389","journal-title":"Artif Cells Substit Immobil Biotechnol"},{"issue":"5","key":"8495_CR16","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1016\/0735-1097(95)00306-1","volume":"26","author":"PA Grayburn","year":"1995","unstructured":"Grayburn PA, Erickson JM, Excobar J, Womack L, Velasco CE (1995) Peripheral intravenous myocardial contrast echocardiography using a 2% dodecafluoropentane emulsion: identification of myocardial risk area and infarct size in the canine model of ischemia. J Am Coll Cardiol 26(5):1340\u20131347","journal-title":"J Am Coll Cardiol"},{"key":"8495_CR17","unstructured":"Khor SP (2012) Amendment to the pharmacokinetic analysis of clinical data from study SON-3600-1004a: NuvOx Formal Study Report"},{"key":"8495_CR18","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0301-5629(00)00363-X","volume":"27","author":"JM Correas","year":"2001","unstructured":"Correas JM, Meuter AR, Singlas E, Kessler DR, Worah D, Quay SC (2001) Human pharmacokinetics of a perfluorocarbon ultrasound contrast agent evaluated with gas chromatography. Ultrasound Med Biol 27:565\u2013570","journal-title":"Ultrasound Med Biol"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-013-8495-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12035-013-8495-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-013-8495-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T02:41:55Z","timestamp":1559443315000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12035-013-8495-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6,28]]},"references-count":18,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,10]]}},"alternative-id":["8495"],"URL":"https:\/\/doi.org\/10.1007\/s12035-013-8495-6","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,6,28]]}}}